Hartmann, Steffi http://orcid.org/0000-0002-0145-1589
Banys-Paluchowski, Maggie http://orcid.org/0000-0002-2374-9482
Stickeler, Elmar http://orcid.org/0000-0002-9715-7260
de Boniface, Jana http://orcid.org/0000-0001-9518-0902
Gentilini, Oreste Davide http://orcid.org/0000-0002-4489-1867
Kontos, Michalis
Seitz, Stephan
Kaltenecker, Gabriele
Wärnberg, Fredrik http://orcid.org/0000-0002-6274-2435
Zetterlund, Linda Holmstrand http://orcid.org/0000-0002-4774-5945
Kolberg, Hans-Christian http://orcid.org/0000-0003-0221-3272
Fröhlich, Sarah
Kühn, Thorsten http://orcid.org/0000-0002-8708-2824
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 16 July 2023
Accepted: 17 August 2023
First Online: 8 September 2023
Declarations
:
: Steffi Hartmann, Elmar Stickeler, Jana De Boniface, Oreste Davide Gentilini, Michalis Kontos, Stephan Seitz, Gabriele Kaltenecker, Linda Holmstrand Zetterlund, and Sarah Fröhlich have no relevant financial or non-financial interests to disclose. Maggie Banys-Paluchowski receives fees for lectures and advisory activities from Roche, Novartis, Pfizer, pfm, Eli Lilly, Onkowissen, Seagen, AstraZeneca, Eisai, Amgen, Samsung, Canon, MSD, GSK, Daiichi Sankyo, Gilead, Sirius Medical, Syantra, resitu, Pierre Fabre, ExactSciences, study support from EndoMag, Mammotome, MeritMedical, Sirius Medical, Gilead, Hologic, and ExactSciences, and travel support from Eli Lilly, ExactSciences, Pierre Fabre, Pfizer, Daiichi Sankyo, and Roche. Fredrik Wärnberg has recent and ongoing research collaboration with Endomagnetics Ltd. Institutional, funding has been received by Sahlgrenska University Hospital from Endomag. Hans-Christian Kolberg has received fees from Pfizer, Seagen, Novartis, Roche, Genomic Health/Exact Sciences, Amgen, AstraZeneca, Riemser, Carl Zeiss Meditec, TEVA, Theraclion, Janssen-Cilag, GSK, LIV Pharma, Lilly, SurgVision, Onkowissen, Gilead, Daiichi Sankyo, Sysmex and MSD, travel support from Carl Zeiss meditec, LIV Pharma, Novartis, Amgen, Pfizer, Daiichi Sankyo and Tesaro, and holds stock of Theraclion SA und Phaon Scientific GmbH. Thorsten Kühn received fees from Gilead, Pfizer, MSD, Lilly, Astra Zeneca, Exact Sciences, Endomag, Hologic, Merit Medical, and Sirius Medical.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Aachen, Germany (Date: April 28, 2020, Number: EK 013/20).
: Informed consent was obtained from all individual participants included in the study.